Related Experiment Video
Updated: Sep 29, 2025

11:00
Real-Time Quantification of Reactive Oxygen Species in Neutrophils Infected with Meningitic Escherichia Coli
Published on: April 20, 2021
4.5K
An Integrated Pharmacological, Structural, and Genetic Analysis of Extracellular Versus Intracellular ROS Production
Christian D Ellson1, Ingred Goretti Riça1, Jacob S Kim1
1Departments of Biology and Biological Engineering, and Center for Precision Cancer Medicine, David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute for Technology, Cambridge, MA 02139, USA.
Journal of Molecular Biology
|March 22, 2022
Summary
This study identifies p110β and PLD1 as key regulators of extracellular reactive oxygen species (ROS) production in neutrophils. Targeting the p47phox PX domain could modulate inflammation and related diseases.
Area of Science:
- Immunology
- Cell Biology
- Biochemistry
Background:
- Neutrophil NADPH oxidase generates reactive oxygen species (ROS), crucial for immunity but implicated in inflammatory damage, cancer, and immune dysregulation.
- The precise signaling pathways governing ROS localization (intracellular vs. extracellular) remain incompletely understood.
Purpose of the Study:
- To elucidate the specific signaling pathways regulating extracellular ROS production in neutrophils.
- To identify molecular targets for controlling ROS-mediated inflammation and disease.
Main Methods:
- Systems pharmacology approach to identify key signaling molecules.
- Crystallography and molecular dynamics to analyze the p47phox PX domain.
- Generation and analysis of p47phox K43A mutant mice.
Main Results:
- Class I PI3-K isoform p110β and PLD1, but not PLD2, were identified as critical regulators of extracellular ROS production.
- Structural analysis clarified the membrane-binding mechanism of the p47phox PX domain.
- Neutrophils from p47phox K43A mutant mice showed specific deficiency in extracellular ROS production, highlighting the PX domain's role.
Conclusions:
- The p47phox PX domain integrates p110β and PLD1 signaling to control extracellular ROS production.
- This signaling axis represents a potential therapeutic target for inflammatory conditions, cancer, and immune dysregulation.
Keywords:
Extracellular and intracellular ROSNADPH oxidaseNeutrophilPI 3-kinasePX domainSystems pharmacology
